Terri B. Sebree
2019
In 2019, Terri B. Sebree earned a total compensation of $1M as President at Zynerba Pharmaceuticals, a 19% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $252,144 |
---|---|
Option Awards | $309,861 |
Salary | $437,750 |
Stock Awards | $13,140 |
Other | $25,985 |
Total | $1,038,880 |
Sebree received $437.8K in salary, accounting for 42% of the total pay in 2019.
Sebree also received $252.1K in non-equity incentive plan, $309.9K in option awards, $13.1K in stock awards and $26K in other compensation.
Rankings
In 2019, Terri B. Sebree's compensation ranked 9,125th out of 13,971 executives tracked by ExecPay. In other words, Sebree earned more than 34.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,125 | 35th |
Manufacturing | 3,659 | 36th |
Chemicals And Allied Products | 1,385 | 37th |
Drugs | 1,182 | 37th |
Pharmaceutical Preparations | 876 | 37th |
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2019.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019